Literature DB >> 15964020

Preconditioned hyperbaric oxygenation protects the liver against ischemia-reperfusion injury in rats.

Shi-Yau Yu1, Jen-Hwey Chiu, Shiaw-Der Yang, Hsi-Yu Yu, Cheng-Chu Hsieh, Pei-Ju Chen, Wing-Yiu Lui, Chew-Wun Wu.   

Abstract

Hyperbaric oxygen (HBO) therapy is an effective adjunct in treating ischemia-reperfusion (I/R) injury of brain, small intestine, testis, and crushing extremities. This study was designed to test the hypotheses that preconditioning the rats with HBO could protect the liver against subsequent I/R injury. Daily treatment with one-dose HBO (90 min, 2.5 ATA) was brought about for male Sprague Dawley rats for 1 to 3 days before an I/R injury of liver. Hepatic expression of heat-shock protein 70 (Hsp70), total concentration of glutathione (GSH), activity of catalase, superoxide dismutase (SOD), and serum AST and ALT were estimated before and after HBO, as well as after I/R injury. The results showed that activity of hepatic catalase was decreased by one dose, but not three doses, of HBO as compared with baseline data. However, hepatic Hsp70 expression fluctuated insignificantly. AST and ALT increase less in rats preconditioned with one-dose HBO as compared with those without HBO or with three-dose HBO. Our results showed preconditioning by one-dose HBO protects rat liver against subsequent ischemia-reperfusion injury.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15964020     DOI: 10.1016/j.jss.2005.04.025

Source DB:  PubMed          Journal:  J Surg Res        ISSN: 0022-4804            Impact factor:   2.192


  25 in total

1.  Wound healing from a cellular stress response perspective.

Authors:  Bindi M Doshi; George A Perdrizet; Lawrence E Hightower
Journal:  Cell Stress Chaperones       Date:  2008-07-15       Impact factor: 3.667

Review 2.  Oxidative stress is fundamental to hyperbaric oxygen therapy.

Authors:  Stephen R Thom
Journal:  J Appl Physiol (1985)       Date:  2008-10-09

3.  Comparison of the effects of 40% oxygen and two atmospheric absolute air pressure conditions on stress-induced premature senescence of normal human diploid fibroblasts.

Authors:  Sangnam Oh; Eunil Lee; Joohyun Lee; Yongchul Lim; Joonhee Kim; Samyong Woo
Journal:  Cell Stress Chaperones       Date:  2008-05-09       Impact factor: 3.667

Review 4.  Hyperbaric oxygen: its mechanisms and efficacy.

Authors:  Stephen R Thom
Journal:  Plast Reconstr Surg       Date:  2011-01       Impact factor: 4.730

5.  COVID-19, acute respiratory distress syndrome (ARDS), and hyperbaric oxygen therapy (HBOT): what is the link?

Authors:  Antonio De Maio; Lawrence E Hightower
Journal:  Cell Stress Chaperones       Date:  2020-09       Impact factor: 3.667

Review 6.  Ischemia/reperfusion injury in liver resection: a review of preconditioning methods.

Authors:  Kassiani Theodoraki; Aliki Tympa; Iosifina Karmaniolou; Athanassia Tsaroucha; Nikolaos Arkadopoulos; Vassilios Smyrniotis
Journal:  Surg Today       Date:  2011-05-01       Impact factor: 2.549

7.  Early hyperbaric oxygen therapy improves survival in a model of severe sepsis.

Authors:  Jonathan L Halbach; James M Prieto; Andrew W Wang; Dennis Hawisher; David M Cauvi; Tony Reyes; Jonathan Okerblom; Israel Ramirez-Sanchez; Francisco Villarreal; Hemal H Patel; Stephen W Bickler; George A Perdrizet; Antonio De Maio
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2019-05-15       Impact factor: 3.619

8.  Recent advances in liver preconditioning: Thyroid hormone, n-3 long-chain polyunsaturated fatty acids and iron.

Authors:  Virginia Fernández; Gladys Tapia; Luis A Videla
Journal:  World J Hepatol       Date:  2012-04-27

9.  Hyperbaric oxygen preconditioning attenuates hyperglycemia enhanced hemorrhagic transformation after transient MCAO in rats.

Authors:  Yoshiteru Soejima; Robert P Ostrowski; Anatol Manaenko; Mutsumi Fujii; Jiping Tang; John H Zhang
Journal:  Med Gas Res       Date:  2012-04-11

10.  Short-time intermittent preexposure of living human donors to hyperoxia improves renal function in early posttransplant period: a double-blind randomized clinical trial.

Authors:  Kamran Montazeri; Mohammadali Vakily; Azim Honarmand; Parviz Kashefi; Mohammadreza Safavi; Shahram Taheri; Bahram Rasoulian
Journal:  J Transplant       Date:  2011-04-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.